belimumab
Showing 1 - 25 of 32
Systemic Lupus Erythematosus Trial (Belimumab, Standard of care)
Not yet recruiting
- Systemic Lupus Erythematosus
- Belimumab
- Standard of care
- (no location specified)
Jun 14, 2023
Belimumab In Prevention of LN
Not yet recruiting
- Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
- Belimumab
- (no location specified)
Oct 14, 2022
Telitacicept and Belimumab in Active Lupus Nephritis in Real
Not yet recruiting
- Lupus Nephritis
- +2 more
- Belimumab
- Telitacicept
- (no location specified)
Oct 18, 2022
Lupus Erythematosus, Systemic Trial in Beijing (Belimumab, Standard of care)
Completed
- Lupus Erythematosus, Systemic
- Belimumab
- Standard of care
-
Beijing, Dongcheng, ChinaPeking Union Medical College hospital
Jul 5, 2022
Antiphospholipid Syndrome Trial in Turin (Belimumab)
Recruiting
- Antiphospholipid Syndrome
- Belimumab
-
Turin, Piedmont, ItalySan Giovanni Bosco Hospital
May 20, 2022
Systemic Lupus Erythematosus Trial in Wilmington (belimumab)
Completed
- Systemic Lupus Erythematosus
- belimumab
-
Wilmington, North Carolina
- +15 more
Jan 19, 2023
COPD, Emphysema Trial in Birmingham (Belimumab, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Belimumab
- Placebo
-
Birmingham, AlabamaUAB Lung Health Center
Apr 4, 2022
Systemic Lupus Erythematosus Trial in Beijing (Belimumab, Interleukin-2)
Recruiting
- Systemic Lupus Erythematosus
- Belimumab
- Interleukin-2
-
Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Mar 24, 2022
Systemic Lupus Erythematosus Trial (Belimumab)
Not yet recruiting
- Systemic Lupus Erythematosus
- Belimumab
- (no location specified)
Jan 12, 2022
Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)
Recruiting
- Membranous Nephropathy
- Nephrotic Syndrome
- Belimumab
- +2 more
-
Birmingham, Alabama
- +16 more
Sep 22, 2022
ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)
Active, not recruiting
- ANCA Associated Vasculitis
- Granulomatosis With Polyangiitis
- Belimumab
- +2 more
-
Cambridge, United Kingdom
- +5 more
Feb 21, 2022
Systemic Lupus Erythematosus Trial (Belimumab, Standard therapy)
Not yet recruiting
- Systemic Lupus Erythematosus
- Belimumab
- Standard therapy
- (no location specified)
Sep 29, 2021
Multiple Sclerosis Trial in Baltimore (Belimumab, Short-course Ocrelizumab, Continued Ocrelizumab)
Recruiting
- Multiple Sclerosis
- Belimumab
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Oct 7, 2021
Vasculitis, Cryoglobulinemia Trial (Belimumab, Placebo)
Not yet recruiting
- Vasculitis
- Cryoglobulinemia
- Belimumab
- Placebo
- (no location specified)
Nov 9, 2020
Transcriptional and Immine Parameters of Response to Belinumab
Not yet recruiting
- Systemic Lupus Erythematosus
- Belimumab
- (no location specified)
Dec 4, 2020
Systemic Lupus Erythematosus Trial in Worldwide (Belimumab, Rituximab, Rituximab-)
Completed
- Systemic Lupus Erythematosus
- Belimumab
- +5 more
-
Birmingham, Alabama
- +78 more
Mar 25, 2022
Myositis Trial in Great Neck (Belimumab, Placebo)
Unknown status
- Myositis
- Belimumab
- Placebo
-
Great Neck, New YorkNorthwell Health Divison of Rheumatology
Sep 6, 2019
Systemic Lupus Erythematosus Trial in Worldwide (Belimumab)
Completed
- Systemic Lupus Erythematosus
- Belimumab
-
Los Angeles, California
- +19 more
Jan 21, 2020
Renal Transplant Rejection Trial in Cincinnati (belimumab, Bortezomib, Rituximab)
Completed
- Renal Transplant Rejection
- belimumab
- +3 more
-
Cincinnati, Ohio
- +1 more
Apr 19, 2019
Systemic Lupus Erythematosus Trial in China, Japan, Korea, Republic of (Belimumab, Placebo)
Completed
- Systemic Lupus Erythematosus
- Belimumab
- Placebo
-
Hefei, Anhui, China
- +46 more
Sep 20, 2019
Systemic Lupus Erythematosus Trial in Worldwide (belimumab)
Completed
- Systemic Lupus Erythematosus
- belimumab
-
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- +109 more
Nov 19, 2019
Glomerulonephritis, Membranous Trial in United Kingdom (belimumab)
Completed
- Glomerulonephritis, Membranous
- belimumab
-
Exeter, Devon, United Kingdom
- +7 more
Sep 12, 2017